Terbutaline: level the playing field for inhaled β2-agonists by introducing a dosing and urine threshold | British Journal of Sports Medicine

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Log out
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

For authors

Resources

About

New editors
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals More

You are viewing from: Department GEZ-LTA Erasmushogeschool

Citation Tools

Discussion

Terbutaline: level the playing field for inhaled β₂-agonists by introducing a dosing and urine threshold

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:: Jacobson GA, Hostrup M

Terbutaline: level the playing field for inhaled β₂-agonists by introducing a dosing and urine threshold

British Journal of Sports Medicine 2017;51:1323-1324.